Cargando…
New Insights for RANKL as a Proinflammatory Modulator in Modeled Inflammatory Arthritis
Receptor activator of nuclear factor-κB ligand (RANKL), a member of the Tumor Necrosis Factor (TNF) superfamily, constitutes the master regulator of osteoclast formation and bone resorption, whereas its involvement in inflammatory diseases remains unclear. Here, we used the human TNF transgenic mous...
Autores principales: | Papadaki, Maria, Rinotas, Vagelis, Violitzi, Foteini, Thireou, Trias, Panayotou, George, Samiotaki, Martina, Douni, Eleni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370657/ https://www.ncbi.nlm.nih.gov/pubmed/30804932 http://dx.doi.org/10.3389/fimmu.2019.00097 |
Ejemplares similares
-
A Splicing Mutation in the Novel Mitochondrial Protein DNAJC11 Causes Motor Neuron Pathology Associated with Cristae Disorganization, and Lymphoid Abnormalities in Mice
por: Ioakeimidis, Fotis, et al.
Publicado: (2014) -
In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
por: Melagraki, Georgia, et al.
Publicado: (2018) -
Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
por: Melagraki, Georgia, et al.
Publicado: (2017) -
Structure-Based Discovery of Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-Induced Osteoclastogenesis Inhibitors
por: Rinotas, Vagelis, et al.
Publicado: (2023) -
Α Humanized RANKL Transgenic Mouse Model of Progestin-Induced Mammary Carcinogenesis for Evaluation of Novel Therapeutics
por: Kolokotroni, Anthi, et al.
Publicado: (2023)